Westerkirk Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.52M Sell
38,959
-1,100
-3% -$256K 1.03% 21
2025
Q4
$8.29M Buy
40,059
+5,000
+14% +$989K 0.81% 26
2025
Q3
$6.5M Buy
35,059
+7,775
+28% +$1.33M 0.74% 25
2025
Q2
$4.17M Buy
+27,284
New +$4.19M 0.51% 42

Other funds holding JNJ

Westerkirk Capital's JNJ Position: Q1 2026 in Review

Westerkirk Capital reduced its Johnson & Johnson (JNJ) stake by 2.7% in Q1 2026, selling an estimated $256K and leaving 38,959 shares worth $9.52M. The position accounts for 1.03% of the portfolio, ranked #21.

Westerkirk Capital first reported a position in JNJ in Q2 2025 and has held it in 4 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Westerkirk Capital held 38,959 shares of Johnson & Johnson worth $9.52M as of Q1 2026.
  • Westerkirk Capital sold 1,100 Johnson & Johnson shares in Q1 2026, an estimated $256K.
  • Johnson & Johnson made up 1.03% of Westerkirk Capital's portfolio in Q1 2026, its #21 holding.
  • Westerkirk Capital first reported a position in Johnson & Johnson in Q2 2025 and has held it in 4 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Westerkirk Capital's 13F filing for Q1 2026, filed 14 May 2026.